ATHN 11: Liver Transplantation Outcomes Study (HOT)
An Observational Cohort Study of Long-Term Outcomes of Orthotopic Liver Transplantation in People With Hemophilia
Sponsor: American Thrombosis and Hemostasis Network
Listed as NCT04055051, this observational or N/A phase trial focuses on Hemophilia A and B and Liver Transplantation and remains completed. Sponsored by American Thrombosis and Hemostasis Network, it has been updated 13 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2022 — Jun 2023 [monthly]
Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Sep 2021 — Feb 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
Status: Enrolling By Invitation → Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting
-
Apr 2020 — Jun 2020 [monthly]
Not Yet Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Thrombosis and Hemostasis Network
- BioMarin Pharmaceutical
For direct contact, visit the study record on ClinicalTrials.gov .